secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0001104659-24-109401
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences issues $833,333 senior secured convertible note to institutional investor
--------------------------------------------------------------------------------

- Issued $833,333.34 convertible note with 10% annual interest, due Jan 16, 2025 or upon close of Vyome merger.
- Investor received 7,983 shares of common stock as commitment shares in connection with the note.
- Note is secured by substantially all assets of ReShape Lifesciences, including intellectual property and patents.
- Directors and officers entered lock-up agreements barring disposal of company shares while note is outstanding.
- Investor agreed to a leak-out restriction limiting daily sales to 10% of composite trading volume of RSLS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924109401/0001104659-24-109401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924109401/tm2426316d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-109401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer